These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 23910932)

  • 21. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.
    Lilleri D; Gerna G; Bruno F; Draghi P; Gabanti E; Fornara C; Meloni F
    New Microbiol; 2013 Jul; 36(3):267-77. PubMed ID: 23912868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
    Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
    J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation.
    Morita Y; Hosokawa M; Ebisawa M; Sugita T; Miura O; Takaue Y; Heike Y
    Bone Marrow Transplant; 2005 Nov; 36(9):803-11. PubMed ID: 16113668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytomegalovirus-specific T cells immune reconstitution after human leukocyte antigen matched sibling donor allogeneic bone marrow plus peripheral blood hematopoietic stem cell transplantation].
    Luo XH; Chang YJ; Huo MR; Li D; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):605-9. PubMed ID: 23134850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
    Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
    J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
    Meng XJ; Lin MF; Cai Z
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.
    Mohty M; Mohty AM; Blaise D; Faucher C; Bilger K; Isnardon D; Sainty D; Gastaut JA; Viens P; Olive D; Gaugler B
    Bone Marrow Transplant; 2004 Apr; 33(8):839-46. PubMed ID: 14767500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; Barón AE; Weinberg A
    Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
    Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D
    Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric analysis of virus-specific T lymphocytes: practicability of detection of HCMV-specific T lymphocytes in whole blood in patients after stem cell transplantation.
    Buxbaum S; Kraus FB; Hahn A; Beck O; Kabartas B; Doerr HW; Ludwig B
    J Immunol Methods; 2006 Apr; 311(1-2):164-73. PubMed ID: 16530782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients.
    Lee S; Park JB; Kim EY; Joo SY; Shin EC; Kwon CH; Joh JW; Kim SJ
    Transplant Proc; 2011 Sep; 43(7):2636-40. PubMed ID: 21911137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
    de Pagter AP; Boelens JJ; Scherrenburg J; Vroom-de Blank T; Tesselaar K; Nanlohy N; Sanders EA; Schuurman R; van Baarle D
    Clin Immunol; 2012 Sep; 144(3):179-89. PubMed ID: 22820131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
    Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
    Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.